Hello, Fool! | Login | Signup | My Fool
Jul 20, 2008 6:22 AM ET | Site Changes | Help
Search: Tickers Company Names Players
The Company is a global healthcare group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter medicines and health-related consumer products.
View All Commentary (GSK)
Recs
kahunacfa (< 20) Submitted: 4/29/08 11:29 AM : Start Price: $43.85 GSK Score: 18.31
GlaxoSmithKline, plc is an undervalued major pharmaceutucal company in my opinion. The stock is currently selling near $44.25 per share and has an Intrinsic Value of approximately $74 - $76 per share by my model.GSK is a BUY at $44.25 with a price objective of $75 in three to five years.Kahuna,CFA
Report this Post Replies: 0 | Reply
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Terms & Conditions
RSS Headlines
Fool UK